This topic contains a solution. Click here to go to the answer

Author Question: Which main factor(s) differentiate(s) frontal-subcortical dementias from frontal-temporal dementias? ... (Read 90 times)

shofmannx20

  • Hero Member
  • *****
  • Posts: 562
Which main factor(s) differentiate(s) frontal-subcortical dementias from frontal-temporal dementias?
 
  a) The former affects both motor and cognitive activities.
  b) The latter affects both motor and cognitive activities.
  c) The former affects motor activities, whereas the latter affects cognitive activities
  d) The former affects cognitive activities, whereas the latter affects motor activities.

Question 2

In individuals with Alzheimer's disease, the first area(s) of the brain typically affected by atrophy include:
 
  a) Entorhinal cortex and hippocampus
  b) Parietal lobes
  c) Diencephalon and telencephalon
  d) Frontal lobes



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Juro

  • Sr. Member
  • ****
  • Posts: 337
Answer to Question 1

a

Answer to Question 2

a




shofmannx20

  • Member
  • Posts: 562
Reply 2 on: Jun 22, 2018
Great answer, keep it coming :)


coreycathey

  • Member
  • Posts: 333
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

Eating carrots will improve your eyesight. Carrots are high in vitamin A (retinol), which is essential for good vision. It can also be found in milk, cheese, egg yolks, and liver.

Did you know?

It is important to read food labels and choose foods with low cholesterol and saturated trans fat. You should limit saturated fat to no higher than 6% of daily calories.

Did you know?

Long-term mental and physical effects from substance abuse include: paranoia, psychosis, immune deficiencies, and organ damage.

Did you know?

Alcohol acts as a diuretic. Eight ounces of water is needed to metabolize just 1 ounce of alcohol.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library